| ARCHETYPE ID | openEHR-EHR-CLUSTER.gist_modified_nih.v1 |
|---|---|
| Concept | Modified NIH Criteria for GIST risk assessment |
| Description | An assessment tool used to stratify patients according to their risk of recurrence of Gastrointestinal stromal tumour (GIST) following surgery based on the Modified National Institutes of Health (NIH) Criteria. |
| Use | Use to record the results for each of the component parameters and the risk category for GIST based on the Modified NIH Criteria. The archetype is designed to be used in an ENTRY archetype that will provide the clinical or pathological context. For example: In the "Specific Details" SLOT in the EVALUATION.problem_diagnosis archetype, or nested in a relevant pathology-related CLUSTER archetype that is again nested in the OBSERVATION.laboratory_test_result archetype. This will also allow for documentation of body site. When this archetype needs to be included within an non-OBSERVATION archetype such as EVALUATION.problem_diagnosis, it should first be nested within the CLUSTER.clinical_evidence to provide important context such as the date of the assessment. |
| Misuse | Not to be used for the primary recording of diameter and mitotic count of the tumour - use a relevant pathology-related archetype for this purpose. |
| Purpose | To record the results for each of the component parameters and the risk category for GIST based on the Modified NIH Criteria. |
| References | Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013 Sep 14;382(9896):973-83. doi: 10.1016/S0140-6736(13)60106-3. Epub 2013 Apr 24. Review. PubMed PMID: 23623056 Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008 Oct;39(10):1411-9. doi: 10.1016/j.humpath.2008.06.025. PubMed PMID: 18774375. Jones RL. Practical aspects of risk assessment in gastrointestinal stromal tumors. J Gastrointest Cancer. 2014 Sep;45(3):262-7. doi: 10.1007/s12029-014-9615-x. Review. PubMed PMID: 24802226; PubMed Central PMCID: PMC4126997. Serrano C, Álvarez R, Carrasco JA, Marquina G, Martínez-García J, Martínez-Marín V, Sala MÁ, Sebio A, Sevilla I, Martín-Broto J. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clin Transl Oncol. 2023 Sep;25(9):2707-2717. doi: 10.1007/s12094-023-03177-7. Epub 2023 May 2. PMID: 37129716; PMCID: PMC10425520. Norwegian translation: Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av sarkom. [revised 2022 February]. [Internet]. 2022 February. Available from: https://www.helsedirektoratet.no/retningslinjer/sarkomer-handlingsprogram |
| Copyright | © openEHR Foundation |
| Authors | Author name: Kanika Kuwelker Organisation: Helse Vest IKT Email: kanika.kuwelker@helse-vest-ikt.no Date originally authored: 2024-03-19 |
| Other Details Language | Author name: Kanika Kuwelker Organisation: Helse Vest IKT Email: kanika.kuwelker@helse-vest-ikt.no Date originally authored: 2024-03-19 |
| Other Details (Language Independent) |
|
| Keywords | gastrointestinal stromal tumour, tumor, GIST, sarcoma, cancer, neoplasm, oncology, malignancy, risk, risk assessment, risk stratification, classification, categorisation |
| Lifecycle | published |
| UID | a217bc9f-1a24-4277-bc6b-34231fc93bb6 |
| Language used | en |
| Citeable Identifier | 1246.145.2545 |
| Revision Number | 1.0.0 |
| Archetype Concept Comment | Also known as Joensuu criteria. |
| items | |
| Diameter | Diameter: Largest diameter of tumour. In clinical practice the primary registration of the tumour diameter would be recorded using a relevant pathology-related archetype. In this case, the ‘Diameter’ result in this archetype should be copied from the primary recording. Property: Length Units: >=0.0 cm Limit decimal places: 1 |
| Mitotic count | Mitotic count: Mitotic count of tumour. In clinical practice the primary registration of the mitotic count would be recorded using a relevant pathology-related archetype. In this case, the ‘Mitotic count’ result in this archetype should be copied from the primary recording. Property: null Units:
|
| Location | Location: Location of tumour.
|
| Tumour rupture | Tumour rupture: Presence of tumour rupture.
|
| Risk category | Risk category: Risk of recurrence based on the component parameters, according to the modified NIH criteria.
|
| Other contributors | Vebjørn Arntzen, Oslo University Hospital, Norway (openEHR Editor) Koray Atalag, GALATA-Digital, New Zealand Silje Ljosland Bakke, Helse Vest IKT AS, Norway (openEHR Editor) SB Bhattacharyya, Bhattacharyyas Clinical Records Research & Informatics LLP, India Anthony Burton Mariathasan, OUS, Radiumhospitalet, Norway Grant Forrest, Lunaria Ltd, United Kingdom Marianne Gårderhagen, OUS, Norway Evelyn Hovenga, EJSH Consulting, Australia June Marie Nepstad Knappskog, Helse Nord IKT AS, Norway (openEHR Editor), Norway (openEHR Editor) Kanika Kuwelker, Helse Vest IKT, Norway (openEHR Editor) Jörgen Kuylenstierna, eWeave AB, Sweden Liv Laugen, Oslo University Hospital, Norway, Norway (openEHR Editor) Heather Leslie, Atomica Informatics, Australia (openEHR Editor) Nina Louise Jebsen, Haukeland Universitetssykehus, Norway June Marie Knappskog, Helse Nord IKT AS, Norway (Nasjonal IKT redaktør), Norway Ian McNicoll, freshEHR Clinical Informatics, United Kingdom Olha Nikolaieva, University Hospital Basel, Switzerland Mikael Nyström, Cambio Healthcare Systems AB, Sweden Bjørn Næss, DIPS ASA, Norway Sonja Steigen, Universitetssykehuset Nord-Norge, Norway Norwegian Review Summary, Norwegian Public Hospitals, Norway Kanthan Theivendran, NHS, United Kingdom John Tore Valand, Helse Vest IKT, Norway (openEHR Editor) Olga Zaikova, OUS, Radiumhospitalet, Norway |
| Translators |